Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $5.60B.
ENTERPRISE VALUE (EV)
$5.60B
Kiniksa Pharmaceuticals International, plc
Market Cap
$5.76B
Enterprise Value (EV)
$5.60B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | $5.76B | $5.60B |
| CG Oncology Inc. (CGON)vs › | $5.67B | $5.66B |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.90B | $5.83B |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.92B | $6.05B |
| RadNet, Inc. (RDNT)vs › | $5.54B | $7.00B |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.53B | $5.38B |
| GRAIL Inc. (GRAL)vs › | $6.02B | $6.06B |
| Doximity, Inc. (DOCS)vs › | $5.32B | $5.06B |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | $4.96B |
| Sotera Health Company (SHC)vs › | $5.27B | $7.19B |
Market Cap
$5.76B
Total Debt
$2.99M
Cash
$165.60M
Enterprise Value
$5.60B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
